# EDGAR Filing Document

**Accession Number:** 0001773156
**File Stem:** 0000929638-23-000811
**Filing Date:** 2023-3
**Character Count:** 9706
**Document Hash:** 0d36814c1695e9ca4527090cae66dbc2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000929638-23-000811.hdr.sgml**: 20230308

**ACCESSION NUMBER**: 0000929638-23-000811

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230306

**FILED AS OF DATE**: 20230308

**DATE AS OF CHANGE**: 20230308

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lind Global Macro Fund LP
- **CENTRAL INDEX KEY:** 0001773156
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36612
- **FILM NUMBER:** 23716551

**BUSINESS ADDRESS:**
- **STREET 1:** 444 MADISON AVE, FLOOR 41
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 646-395-3931

**MAIL ADDRESS:**
- **STREET 1:** 444 MADISON AVE, FLOOR 41
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lind Global Fund II LP
- **CENTRAL INDEX KEY:** 0001871665
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36612
- **FILM NUMBER:** 23716552

**BUSINESS ADDRESS:**
- **STREET 1:** 444 MADISON AVENUE
- **STREET 2:** 41ST FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 646-701-7428

**MAIL ADDRESS:**
- **STREET 1:** 444 MADISON AVENUE
- **STREET 2:** 41ST FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ReWalk Robotics Ltd.
- **CENTRAL INDEX KEY:** 0001607962
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3 HATNUFA ST.
- **STREET 2:** FLOOR 6
- **CITY:** YOKNEAM ILIT
- **STATE:** L3
- **ZIP:** 2069203
- **BUSINESS PHONE:** 97249590123

**MAIL ADDRESS:**
- **STREET 1:** 3 HATNUFA ST.
- **STREET 2:** FLOOR 6
- **CITY:** YOKNEAM ILIT
- **STATE:** L3
- **ZIP:** 2069203

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Argo Medical Technologies Ltd.
- **DATE OF NAME CHANGE:** 20140513

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lind Global Fund II LP<br><sub>(Last) (First) (Middle)</sub><br>444 MADISON AVENUE<br>41ST FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10022<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-06 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ReWalk Robotics Ltd. [ RWLK ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lind Global Macro Fund LP<br><sub>(Last) (First) (Middle)</sub><br>444 MADISON AVE, FLOOR 41<br><sub>(Street)</sub><br>NEW YORK, NY 10022<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-06 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ReWalk Robotics Ltd. [ RWLK ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares, par value NIS 0.25 per share | 2023-03-06 |  | P |  | 51049 | A | 0.79<sup>(1)</sup> | 4500482 | I | See footnote<sup>(2)</sup> |
| Ordinary Shares, par value NIS 0.25 per share | 2023-03-06 |  | P |  | 51049 | A | 0.79<sup>(1)</sup> | 4963633 | I | See footnote<sup>(3)</sup> |
| Ordinary Shares, par value NIS 0.25 per share | 2023-03-07 |  | P |  | 67568 | A | 0.8<sup>(4)</sup> | 4568050 | I | See footnote<sup>(2)</sup> |
| Ordinary Shares, par value NIS 0.25 per share | 2023-03-07 |  | P |  | 67567 | A | 0.8<sup>(4)</sup> | 5031200 | I | See footnote<sup>(3)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares purchased ranged from $0.79 to $0.82. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.

(2) Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

(3) Reflects securities held directly by Lind Global Macro Fund LP. Lind Global Partners LLC, the general partner of Lind Global Macro Fund LP, and Jeff Easton, the managing member of Lind Global Partners LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

(4) Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares purchased ranged from $0.79 to $0.81. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.

**Signature:** /s/ Lind Global Fund II LP, by: Lind Global Partners II LLC, its General Partner, by: Jeff Easton, its Managing Member  
**Date:** 2023-03-08

**Signature:** /s/ Lind Global Macro Fund, LP, by: Lind Global Partners LLC, its General Partner, by: Jeff Easton, its Managing Member  
**Date:** 2023-03-08

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**